Related Experiment Video
Updated: Apr 19, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Idiopathic facial aseptic granuloma
A J González Rodríguez1, E Jordá Cuevas
1Department of Dermatology, Hospital Clínico Universitario of Valencia, University of Valencia, Valencia, Spain.
Idiopathic facial aseptic granuloma (IFAG) is a rare childhood condition with unknown causes. Topical antibiotics effectively treated IFAG in two pediatric cases, leading to full recovery without lasting effects.
Area of Science:
- Dermatology
- Pediatrics
- Pathology
Background:
- Idiopathic facial aseptic granuloma (IFAG) is a rare but recognized clinical condition.
- Its etiology remains unknown, and it typically affects children.
- The condition is characterized by a benign clinical course, resolving spontaneously within months.
Observation:
- Microbiological investigations for IFAG are consistently negative.
- Histological findings in IFAG are nonspecific, lacking definitive diagnostic markers.
- A potential link between IFAG and childhood granulomatous rosacea is hypothesized.
Findings:
- Two pediatric cases of IFAG were diagnosed and treated.
- Both cases showed complete resolution of symptoms.
- Treatment involved the application of topical antibiotics.
Implications:
- Topical antibiotic therapy appears to be an effective treatment for IFAG.
- IFAG may represent a distinct entity or a variant within the spectrum of granulomatous skin conditions in children.
- Further research is warranted to elucidate the pathogenesis of IFAG.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
09:14Surgical Approach to Full Soft Tissue Face Allograft Procurement for Vascularized Composite Allotransplantation
Published on: December 30, 2025
Related Concept Videos
Chronic Inflammation: Introduction
Myasthenia Gravis ll: Pathophysiology
Brain Abscess l: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Graves' Disease I: Introduction
Rheumatic Heart Disease I: Introduction